Sequenom and GlaxoSmithKline to Validate SNPs, DNA Samples Linked to Diabetes | GenomeWeb

NEW YORK, Jan 17 – Sequenom and GlaxoSmithKline have embarked upon a collaborative project to validate 500 SNPs and over 900 DNA samples from people with Type 2 Diabetes, Sequenom said Wednesday.

 

   

" Our objective is to screen hundreds of SNPs that we have localized to a

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.